News Feed Item

New Frost & Sullivan Analysis Shows ON-Q* Pain Pump as Clinicians' Preferred Post-Operative Pain Management Choice Compared to Exparel

Anesthesiologists and hospital pharmacy managers report ON-Q provides superior pain control over the full length of the post-operative period, and at a lower cost

NEW ORLEANS, March 10, 2014 /PRNewswire/ -- AAOS -- I-Flow, LLC, a Kimberly-Clark Health Care Company and manufacturer of the ON-Q Pain Relief System (ON-Q), today announced top-line findings of a Frost & Sullivan whitepaper documenting clinician perspective that ON-Q delivers superior pain control over the full length of the post-operative period, and at a lower cost compared to Exparel.  The full paper is scheduled for release in April 2014.

The whitepaper analyzes the literature and clinical experience behind the ON-Q Pain Relief System and Pacira's Exparel (bupivacaine liposome injectable suspension), and illuminates the most important criteria for clinicians to consider when evaluating post-operative pain management alternatives.

According to the anesthesiologists involved in the research, the actual duration of pain relief for Exparel was significantly shorter than marketed – 25 versus 72 hours. While Exparel provided better pain relief up to 12 hours for orthopedic surgery, ON-Q provided superior pain relief from that point forward up to 96 hours, making it the ideal choice for longer-term pain management. Additionally, one-third of patients are receiving more than one dose of Exparel and adjunctive drugs are used in the majority of cases, adding additional costs.

"Clinicians are telling us that pain is personal, and one-size does not fit all," said Charlie Whelan, Whitepaper Lead Analyst, Frost & Sullivan. "ON-Q's ability to adapt to the changing pain relief needs that patients have over the first five days following surgery, and not just the first 12 or 24 hours, makes it the preferred choice for patients, surgeons and anesthesiologists alike."

Frost & Sullivan identified three criteria that establish ON-Q as the preferred choice of those surveyed over Exparel for post-operative pain management:

  • Greater economic value across the entire post-operative period
  • Proven clinical effectiveness specific to individual patient needs
  • Safety and predictability rooted in evidence

"While Exparel has been touted as a more cost-effective alternative to post-operative pain pumps, the actual economics in a clinical setting suggest otherwise," noted Alan Dine, Senior Director Clinical Research, I-Flow. "With an increasing focus on minimizing excess cost, improving patient satisfaction and avoiding readmissions, it's essential for hospitals to analyze the economic impact of their post-operative pain management approach."

To schedule an interview or learn more about this whitepaper, visit I-Flow booth #6449 during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting or email [email protected].

Frost & Sullivan performed a literature search, administered a survey to a random sample of 31 anesthesiologists and 32 pharmacy directors at U.S. hospitals who had experience with both ON-Q and Exparel and conducted in-depth interviews with a subset of participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting, and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates, and implements effective growth strategies. Frost & Sullivan employs over 50 years of experience in partnering with Global 1000 companies, emerging businesses, and the investment community from more than 45 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit http://www.frost.com.

About I-Flow
I-Flow, LLC, a Kimberly-Clark Health Care Company, is a global market leader in acute pain and ambulatory medication delivery, driving innovative clinical applications for surgical procedures and regional anesthesia that improve outcomes and advance patient care. Led by its surgical pain management line, the ON-Q Pain Relief System (ON-Q) provides reliable and simple non-narcotic, regional anesthesia therapies that are redefining post-surgical recovery by reducing many of the side effects customarily associated with narcotics. Clinical studies have shown that patients who receive ON-Q products generally get back to normal faster after surgery, resulting in shorter hospital stays, reduced costs and higher patient satisfaction. I-Flow also offers a comprehensive suite of kits and trays for performing peripheral nerve blocks, providing an unmet need and total product solution for I-Flow's clinician customers. Also as part of I-Flow's total solution, the Company offers in-depth training, education, consulting and clinical support along with medical device expertise. For more information, visit www.iflo.com.


More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
As IoT continues to increase momentum, so does the associated risk. Secure Device Lifecycle Management (DLM) is ranked as one of the most important technology areas of IoT. Driving this trend is the realization that secure support for IoT devices provides companies the ability to deliver high-quality, reliable, secure offerings faster, create new revenue streams, and reduce support costs, all while building a competitive advantage in their markets. In this session, we will use customer use cases...
"NetApp is known as a data management leader but we do a lot more than just data management on-prem with the data centers of our customers. We're also big in the hybrid cloud," explained Wes Talbert, Principal Architect at NetApp, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
Evan Kirstel is an internationally recognized thought leader and social media influencer in IoT (#1 in 2017), Cloud, Data Security (2016), Health Tech (#9 in 2017), Digital Health (#6 in 2016), B2B Marketing (#5 in 2015), AI, Smart Home, Digital (2017), IIoT (#1 in 2017) and Telecom/Wireless/5G. His connections are a "Who's Who" in these technologies, He is in the top 10 most mentioned/re-tweeted by CMOs and CIOs (2016) and have been recently named 5th most influential B2B marketeer in the US. H...
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of bus...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
DXWorldEXPO LLC announced today that "Miami Blockchain Event by FinTechEXPO" has announced that its Call for Papers is now open. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Financial enterprises in New York City, London, Singapore, and other world financial capitals are embracing a new generation of smart, automated FinTech that eliminates many cumbersome, slow, and expe...
As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: implemen...
DXWorldEXPO LLC announced today that ICOHOLDER named "Media Sponsor" of Miami Blockchain Event by FinTechEXPO. ICOHOLDER give you detailed information and help the community to invest in the trusty projects. Miami Blockchain Event by FinTechEXPO has opened its Call for Papers. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Miami Blockchain Event by FinTechEXPO also offers s...
DXWorldEXPO | CloudEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.
@DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises - and delivering real results.